BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30325389)

  • 21. Management of refractory early-stage cutaneous T-cell lymphoma.
    Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
    Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phototherapy for Cutaneous T-Cell Lymphoma.
    Marka A; Carter JB
    Dermatol Clin; 2020 Jan; 38(1):127-135. PubMed ID: 31753185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current therapy concepts in cutaneous T-cell lymphomas].
    Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
    Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic therapy of cutaneous T-cell lymphoma (CTCL).
    Alpdogan O; Kartan S; Johnson W; Sokol K; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):10. PubMed ID: 30818958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management strategies for cutaneous T-cell lymphoma.
    Knobler E
    Clin Dermatol; 2004; 22(3):197-208. PubMed ID: 15262305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
    Wieser I; Oh CW; Talpur R; Duvic M
    J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
    Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
    Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Cutaneous Lymphomas in Children and Adolescents.
    Ceppi F; Pope E; Ngan B; Abla O
    Pediatr Blood Cancer; 2016 Nov; 63(11):1886-94. PubMed ID: 27229270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phototherapy of Mycosis Fungoides.
    Hodak E; Pavlovsky L
    Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging new therapies for cutaneous T-cell lymphoma.
    Duvic M; Cather JC
    Dermatol Clin; 2000 Jan; 18(1):147-56. PubMed ID: 10626120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy.
    Laws PM; Shear NH; Pope E
    Pediatr Dermatol; 2014; 31(4):459-64. PubMed ID: 24916067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photochemotherapy for mycosis fungoides.
    Roenigk HH
    Arch Dermatol; 1977 Aug; 113(8):1047-51. PubMed ID: 889332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The First Year of the AEVD Primary Cutaneous Lymphoma Registry.
    Peñate Y; Servitje O; Machan S; Fernández-de-Misa R; Estrach MT; Acebo E; Mitxelena J; Ramón MD; Flórez A; Blanes M; Morillo M; Medina S; Bassas J; Zayas A; Espinosa P; Pérez A; Gónzalez-Romero N; Domínguez JD; Muniesa C; López Robles J; Combalia A; Yanguas I; Suh H; Polo-Rodríguez I; Bielsa I; Mateu A; Ferrer B; Descalzo MA; García-Doval I; Ortiz-Romero PL
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):610-616. PubMed ID: 29680323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
    Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
    An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on skin directed therapies in mycosis fungoides.
    Lovgren ML; Scarisbrick JJ
    Chin Clin Oncol; 2019 Feb; 8(1):7. PubMed ID: 30525757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P; Fierro MT; Rossotto GL; Savoia P; Bernengo MG
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.